Fintel reports that on February 6, 2025, Exane BNP Paribas upgraded their outlook for Array Technologies (NasdaqGM:ARRY) from Underperform to Neutral. Analyst Price Forecast Suggests 35.25% Upside As ...

Exane BNP Paribas analyst Moses Sutton upgraded Array Technologies (ARRY) to Neutral from Underperform with a $9 price target Maximize Your ...

Exane BNP Paribas downgraded Weir Group (WEGRY) to Neutral from Outperform with a 2,270 GBp price target The firm thinks the company may miss ...

Exane analyst Christoph Blieffert downgraded the stock rating for Valmet Oyj (VALMT:FH) (OTC: VOYJF) from Outperform to Neutral. Accompanying this downgrade, the price target was also adjusted from ...

Exane BNP Paribas upgraded Adobe Inc. (NASDAQ:ADBE) to Neutral from Underperform and raised the stock's price target to $425. The analyst views better risks and rewards consideration on Adobe for ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (OTCPK:NONOF) from Neutral to Outperform. As of December 23, 2024, the average one-year price ...

The following trades were made in the first half of 2024: 346,002 securities were purchased for a total of €10,218,263 (2,262 transactions) 329,474 securities were sold for a total of € ...

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (XTRA:NOV) from Neutral to Outperform. As of December 23, 2024, the average one-year price ...

Exane BNP Paribas upgraded Adobe Inc. (NASDAQ:ADBE) to Neutral from Underperform and raised the stock's price target to $425. The analyst views better risks and rewards consideration on Adobe for its ...